{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:17:48Z","timestamp":1694625468164},"reference-count":0,"publisher":"Hogrefe Publishing Group","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:p> Amiodaron ist ein h\u00e4ufig verwendetes Medikament zur Behandlung von Herzrhythmusst\u00f6rungen. Das Nebenwirkungsspektrum ist breit und in etwa 14\u201318% der behandelten Patienten tritt eine Schilddr\u00fcsendysfunktion auf, welche sich sowohl in Form von Hypo- als auch Hyperthyreose \u00e4ussern kann. Dabei stellen uns vor allem die Hyperthyreosen regelm\u00e4ssig vor diagnostische und therapeutische Probleme und Amiodaron-induzierte Thyreotoxikosen werden je nach pathophysiologischem Mechanismus in drei Gruppen (AIT I, II oder Mischformen) eingeteilt. Am Beispiel einer Patientin mit einem ungew\u00f6hnlich schweren, protrahierten Verlauf einer Amiodaron-induzierten Thyreotoxikose diskutieren wir die Schwierigkeiten der Diagnostik und Therapie dieses Krankheitsbildes. <\/jats:p>","DOI":"10.1024\/0369-8394.94.36.1397","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T12:14:33Z","timestamp":1138709673000},"page":"1397-1401","source":"Crossref","is-referenced-by-count":0,"title":["Amiodaron-induzierte Thyreotoxikose: Eine diagnostische und therapeutische Herausforderung"],"prefix":"10.1024","volume":"94","author":[{"family":"Schuetz","sequence":"first","affiliation":[{"name":"Abteilung Innere Medizin, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Eriksson","sequence":"additional","affiliation":[{"name":"Abteilung Innere Medizin, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Christ-Crain","sequence":"additional","affiliation":[{"name":"Abteilung Innere Medizin, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Zulewski","sequence":"additional","affiliation":[{"name":"Abteilung Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Abteilung Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/0369-8394.94.36.1397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T11:01:48Z","timestamp":1652007708000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/0369-8394.94.36.1397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":0,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2005,9,1]]}},"alternative-id":["10.1024\/0369-8394.94.36.1397"],"URL":"https:\/\/doi.org\/10.1024\/0369-8394.94.36.1397","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}